Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the...
Main Authors: | Joseph Flores, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, Andréa C. LeBlanc |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18405-9 |
Similar Items
-
Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
by: Joseph Flores, et al.
Published: (2021-04-01) -
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
by: Joseph Flores, et al.
Published: (2018-09-01) -
Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits
by: Anastasia Noël, et al.
Published: (2021-03-01) -
Inflammation-induced tumorigenesis in mouse colon is caspase-6 independent.
by: Bénédicte Foveau, et al.
Published: (2014-01-01) -
Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
by: Zhou, Libin, et al.
Published: (2021)